Ulbig, Michael https://orcid.org/0000-0001-5961-0039
Brinkmann, Christian Karl
Mirshahi, Alireza
Hoerauf, Hans
Allmeier, Helmut
Machewitz, Tobias
Scholz, Paula
Keramas, Georgios
Khoramnia, Ramin
,
Funding for this research was provided by:
Bayer AG
Technische Universität München
Article History
Received: 19 April 2024
Revised: 15 August 2024
Accepted: 15 August 2024
First Online: 17 September 2024
Einhaltung ethischer Richtlinien
:
: M. Ulbig macht folgende Angaben: Grants or contracts from any entity: Alimera, Astrazeneca, Bayer, Novartis, Roche. C.K. Brinkmann macht folgende Angaben: Grants or contracts from any entity: Alimera, Appelis, Afidera, Bayer, Novartis, SandozHexal, Santhera, Teleon. Consulting fees: Abbvie, Bayer. Payment or honoratia for lectures, presentations, speakers bureaus, manuscript writing or educational events: Alimera, Appelis, Afidera, Bayer, Novartis, SandozHexal, Santhera, Thea Pharma, Teleon. Support for attending meetings and/or travel: Alimera, Appelis, Afidera, Bayer, Novartis, SandozHexal, Santhera, Thea Pharma, Teleon, Ursapharm. A. Mirshahi macht folgende Angaben: Grants or contracts from any entitity: Alimera Sciences, Bayer, Carekom, Eyefox, Glaukos, Johnson & Johnson, Novartis, Optimed, Rodenstock, Santen, Ziemer Ophthalmics. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Bayer. Participation on a Data Safety Monitoring Board or Advisory Board: Bayer. H. Hoerauf macht folgende Angaben: Grants or contracts from any entity: Bayer, Novartis, Roche, Abbvie. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Bayer, Novartis, Roche, Abbvie, Biogen, Thea, Alcon. Participation on a Data Safety Monitoring Board or Advisory Board: Bayer, Alcon, Roche, Stadapharm, Abbvie. Stock or stock options: Bayer, Roche, Novartis. H. Allmeier is a full-time employee of Bayer CC AG. He was the overall responsible for the conduct of the Auriga study. T. Machewitz is a full-time employee of Bayer VitalGmbH and was the responsible study statistician and he declares stock or stock options from Bayer. P. Scholz is a full-time employee of Bayer VitalGmbH. G. Keramas is a full-time employee of Bayer VitalGmbH. R. Khoramnia macht folgende Angaben: Grants or contracts from any entity: Bayer, Roche, Chengdu Kanghong, Alimera, Novartis, Opthea. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Bayer, Roche, Abbvie, Alimera, Novartis, Heidelberg Engineering, Apellis. Support for attending meetings and/or travel: Bayer, Roche, Abbvie, Alimera, Novartis, Heidelberg Engineering, Apellis.
: Die Daten dieses Beitrages basieren auf einer nicht-interventionellen Beobachtungsstudie an Menschen, bei der klinische Daten aus der klinischen Behandlungsroutine dokumentiert wurden. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.